UBS has recently initiated Clover Health Investments Corp (CLOV) stock to Neutral rating, as announced on October 7, 2024, according to Finviz. Earlier, on February 2, 2022, Cowen had raised the stock ...

The heavy selling pressure might have exhausted for Clover Health Investments (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall ...

On Friday, Clover Health Investments Corp (CLOV) stock saw a decline, ending the day at $3.41 which represents a decrease of $-0.26 or -7.08% from the prior close of $3.67. The stock opened at $3.69 ...

They set a “neutral” rating and a $4.00 price objective on the stock. CLOV stock opened at $3.41 on Monday. Clover Health Investments has a 12 month low of $0.61 and a 12 month high of $4.71.

A downtrend has been apparent in Clover Health Investments, Corp. (CLOV) lately. While the stock has lost 23.1% over the past week, it could witness a trend reversal as a hammer chart pattern was ...

A downtrend has been apparent in Clover Health Investments, Corp. (CLOV) lately. While the stock has lost 23.1% over the past ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ByInvesting.com • Oct 23, 2024 CLOV stock touches 52-week high at $4.44 amid market rally In a remarkable turn of events, Clover Health Investments Corp. (CLOV) stock has soared to a 52-week ...

In a remarkable turnaround, Clover Health Investments Corp. (CLOV) stock has soared to a 52-week high, reaching $3.48. This peak comes amidst a broader market rally that has seen... In a recent ...